tiprankstipranks
Trending News
More News >
Nova Eye Medical (AU:EYE)
ASX:EYE
Advertisement

Nova Eye Medical (EYE) Price & Analysis

Compare
18 Followers

EYE Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

4.77%95.23%
Mutual Funds
― Other Institutional Investors
95.23% Public Companies and
Individual Investors

EYE FAQ

What was Nova Eye Medical’s price range in the past 12 months?
Nova Eye Medical lowest share price was AU$0.09 and its highest was AU$0.25 in the past 12 months.
    What is Nova Eye Medical’s market cap?
    Nova Eye Medical’s market cap is $41.20M.
      When is Nova Eye Medical’s upcoming earnings report date?
      Nova Eye Medical’s upcoming earnings report date is Aug 27, 2025 which is in 29 days.
        How were Nova Eye Medical’s earnings last quarter?
        Nova Eye Medical released its earnings results on Feb 25, 2025. The company reported -AU$0.024 earnings per share for the quarter, missing the consensus estimate of -AU$0.007 by -AU$0.017.
          Is Nova Eye Medical overvalued?
          According to Wall Street analysts Nova Eye Medical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Nova Eye Medical pay dividends?
            Nova Eye Medical pays a Notavailable dividend of AU$0.414 which represents an annual dividend yield of N/A. See more information on Nova Eye Medical dividends here
              What is Nova Eye Medical’s EPS estimate?
              Nova Eye Medical’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Nova Eye Medical have?
              Nova Eye Medical has 284,153,000 shares outstanding.
                What happened to Nova Eye Medical’s price movement after its last earnings report?
                Nova Eye Medical reported an EPS of -AU$0.024 in its last earnings report, missing expectations of -AU$0.007. Following the earnings report the stock price went down -4.167%.
                  Which hedge fund is a major shareholder of Nova Eye Medical?
                  Currently, no hedge funds are holding shares in AU:EYE

                  Company Description

                  Nova Eye Medical

                  Nova Eye Medical (EYE) is a medical technology company specializing in the development and commercialization of innovative ophthalmic treatment solutions. The company focuses primarily on addressing glaucoma and other eye-related disorders through minimally invasive surgical devices and technologies. Nova Eye Medical operates within the healthcare and medical devices sector, providing cutting-edge solutions designed to improve patient outcomes and enhance the quality of life for individuals with eye health issues.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Compumedics Limited
                  Cyclopharm Limited
                  Micro-X Ltd.
                  EMvision Medical Devices Ltd.
                  Control Bionics Ltd.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis